AI orthodontics adoption 3D Predict has achieved FDA clearance and scaled an AI-driven treatment planning platform, indicating strong potential for expansion into labs and aligner manufacturers seeking validated, compliant software to handle complex cases.

Expansion opportunities The company is shifting focus from being an aligner maker to delivering its software to labs and manufacturers, presenting cross-sell opportunities to partner labs, whitening the collaboration ecosystem and increasing software adoption across the orthodontics value chain.

Revenue potential With reported revenue in the mid to high eight figures and a global treatment planning footprint exceeding 100,000 plans, there is a solid base for upsell of advanced modules, premium support, and enterprise licenses to larger orthodontic networks and manufacturing partners.

Scientific leadership Hiring a Director of Scientific Affairs signals a emphasis on clinical credibility and evidence-based outcomes, creating openings for partnerships in research collaborations, case studies, and co-marketing with academic and clinical centers.

Tech and security A tech stack leveraging cloud, modern web standards, and security features (Cloudflare, HTTP/3) suggests receptiveness to integrations with lab management systems, ERP, and data analytics platforms, enabling joint integrations and data-driven workflows.